@article{0405757528c14b77b0bbcb8facc0e29e,
title = "Conditional survival of patients with metastatic renal-cell carcinoma treated with VEGF-targeted therapy: A population-based study",
author = "Harshman, {Lauren C.} and Wanling Xie and Bjarnason, {Georg A.} and Knox, {Jennifer J.} and Mary MacKenzie and Lori Wood and Sandy Srinivas and Vaishampayan, {Ulka N.} and Tan, {Min Han} and Rha, {Sun Young} and Frede Donskov and Neeraj Agarwal and Christian Kollmannsberger and Scott North and Rini, {Brian I.} and Heng, {Daniel Y.C.} and Choueiri, {Toni K.}",
note = "Funding Information: LCH has a consultant or advisory role at Novartis and Pfizer and has received research funding from Bristol-Myers Squibb, Novartis, and Genentech. GAB has a consultant or advisory role at and has received honoraria and research funding from Pfizer. JJK has a consultant or advisory role at Aveo and and has received research funding from Pfizer. MM has a consultant or advisory role at and has received research funding from Novartis and Pfizer. LW has a consultant or advisory role at Pfizer and Novartis and has received research funding from Pfizer, Novartis, and GlaxoSmithKline. SS has a consultant or advisory role at Pfizer, Novartis, and Genentech. UNV has received honoraria and research funding from Pfizer, Novartis, and GlaxoSmithKline. S-YR has a consultant or advisory role at Novartis, Pfizer, and GlaxoSmithKline, and has received research funding from Novartis and Bayer Korea. FD has received research funding from Novartis. CK has a consultant or advisory role at and has received honoraria and research funding from Pfizer, Novartis, and GlaxoSmithKline. SN has a consultant or advisory role at Pfizer, Novartis, Bayer, and GlaxoSmithKline. BIR has a consultant or advisory role at Pfizer, GlaxoSmithKline, Aveo, and Bayer/Onyx, and has received research funding from GlaxoSmithKline and Pfizer. DYCH has a consultant or advisory role at Pfizer, Novartis, and Bayer/Onyx. TKC has received research funding from Pfizer and has a consultant or advisory role at Aveo, Pfizer, Novartis, GlaxoSmithKline, Genentech, and Bayer/Onyx. WX, M-HT, and NA declare that they have no conflicts of interest. ",
year = "2012",
month = sep,
doi = "10.1016/S1470-2045(12)70285-1",
language = "English",
volume = "13",
pages = "927--935",
journal = "The Lancet Oncology",
issn = "1470-2045",
publisher = "Lancet Publishing Group",
number = "9",
}